[go: up one dir, main page]

WO2025181601A1 - Composition cosmétique pour le soin de l'acné - Google Patents

Composition cosmétique pour le soin de l'acné

Info

Publication number
WO2025181601A1
WO2025181601A1 PCT/IB2025/051414 IB2025051414W WO2025181601A1 WO 2025181601 A1 WO2025181601 A1 WO 2025181601A1 IB 2025051414 W IB2025051414 W IB 2025051414W WO 2025181601 A1 WO2025181601 A1 WO 2025181601A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
care composition
composition
present
acne care
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/IB2025/051414
Other languages
English (en)
Inventor
Changlong CHEN
Siliu Tan
Christopher PANG
Mariko HASABE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US18/591,930 external-priority patent/US20250275908A1/en
Priority claimed from FR2404520A external-priority patent/FR3161561A3/fr
Application filed by LOreal SA filed Critical LOreal SA
Publication of WO2025181601A1 publication Critical patent/WO2025181601A1/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Definitions

  • the present disclosure is directed to a skin care composition, in particular, an acne care composition.
  • the inventors provide here a product formulation in the form of an acne care composition with paste texture that is easy to spread under shear and has good structure without dripping after application and until removal.
  • the acne care composition comprises a) at least one surfactant comprising sodium cocoyl isethionate; b) at least one glycolipid; c) at least one beta hydroxy acid; d) at least one clay; and e) at least one cosmetically acceptable solvent comprising water and glycerin, wherein the acne care composition demonstrates peak shear stress in a range from about 100 to about 1000 PA at shear rate in the range from 1 1/s - 1001/s, followed by a sharp drop in viscosity when shear stress is maintained.
  • the at least one glycolipid is chosen from rhamnolipids, sophorolipids, glucolipids, trehalolipids, cellobiose lipids, mannosylerythritol lipid, or a mixture thereof.
  • the at least one glycolipid is chosen from rhamnolipids present from about 1% to about 4%, by weight, based on the weight of the acne care composition.
  • the at least one beta hydroxy acid comprises salicylic acid or a derivative thereof present from about 0.1% to about 2%, by weight, based on the weight of the acne care composition.
  • the at least one clay comprises kaolin present from about 5% to about 20%, by weight, based on the weight of the acne care composition.
  • glycerin is present from about 10% to about 30%, by weight, based on the weight of the acne care composition.
  • the acne care composition comprises at least one cationic polymer.
  • the at least one cationic polymer is selected from the group consisting of chitosan, chitosan oligosaccharide, chitin, cyclodextrin, cationic gelatin, cationic dextran, cationic cellulose, polylysine, polyornithine, histone, collagen, chitosan-cysteine, chitosan-thiobutylamidine, chitosan-thioglycolic acid, and combinations thereof.
  • the cationic polymer is chitosan present from about 0.05% to about 0.5%, by weight, based on the weight of the acne care composition.
  • the acne care composition comprises at least one thickener.
  • the at least one thickener is chosen from carrageenan, xanthan gum, sclerotium gum, or a combination thereof, and the at least one thickener is present in a range from about 0.1% to about 5%, by weight, based on the weight of the acne care composition.
  • the at least one thickener is carrageenan present from about 0.5% to about 1.5%, by weight, based on the weight of the acne care composition.
  • the acne care composition comprises at least one additive selected from the group consisting of anti-microbials, chelating agents, oils, fillers, penetrants, sequestrants, fragrances, dispersants, skin care actives, and combinations thereof.
  • the acne care composition comprises at least one additive selected from the group consisting of sodium hydroxide, niacinamide, lactic acid, cetyl alcohol, trisodium ethylenediamine disuccinate, ceramides, and combinations thereof.
  • the at least one surfactant comprises glyceryl stearate SE.
  • the pH is from 4.7 - 5.9.
  • the acne care composition comprises a) surfactant comprising sodium cocoyl isethionate present at about 10% and glyceryl stearate SE present at about 5%; b) at least one glycolipid present at about 3%; c) at least one beta hydroxy acid comprising salicylic acid or a derivative thereof present at about 2%; d) at least one clay comprising kaolin present at about 15%; e) at least one cationic polymer comprising chitosan present at about 0.1%; f) at least one thickener comprising one of carrageenan, xanthan gum, sclerotium gum, or a combination thereof present at about 1%; g) at least one cosmetically acceptable solvent comprising water, and comprising glycerin present from about 10% to about 30%; and h) at least one additive selected from the group consisting of sodium hydroxide, niacinamide, lactic acid, cetyl alcohol, trisodium ethylenediamine disuccinate,
  • the at least one additive including sodium hydroxide, niacinamide, lactic acid, cetyl alcohol, trisodium ethylenediamine disuccinate, and ceramides.
  • the disclosure provides a method for cleansing skin comprising applying to the skin of a subject an acne care composition, comprising: a) surfactant comprising sodium cocoyl isethionate and glyceryl stearate SE; b) at least one glycolipid; c) at least one beta hydroxy acid comprising salicylic acid or a derivative thereof; d) at least one clay comprising kaolin; e) at least one cationic polymer comprising chitosan; f) at least one thickener comprising one of carrageenan, xanthan gum, sclerotium gum, or a combination thereof; g) at least one cosmetically acceptable solvent comprising water, and comprising glycerin; and h) at least one additive selected from the group consist
  • the composition is one of (a) in the form of a spot treatment having a paste-like texture which is dotted onto skin and after a selected period of time rinsed off, (b) in the form of a cleanser having a paste-like texture which is applied to skin by rubbing and after a selected period of time rinsed off, and (c) and in the form of a mask having a paste-like texture which is applied to skin by rubbing and retained on the skin for a selected period of time then rinsed off.
  • FIG. 1 is a graph showing change in shear viscosity as a function of shear rate in exemplified compositions
  • FIG. 2 is a graph showing change in shear stress as a function of shear rate in exemplified compositions.
  • FIG. 3 is a graph showing change in shear stress as a function of shear rate in exemplified compositions.
  • compositions for acne care relate to compositions for acne care and methods of using the compositions.
  • the composition is a gentle surfactant based acne care product that may be provided in the form of one or more of a cleanser, mask, or leave on spot treatment, each intended for short term use and removal with at least water.
  • the acne care composition is provided in a versatile antiacne product having a paste-like texture with a relatively thick consistency for leave on use.
  • the acne care composition can be applied on acne spots without any dripping.
  • the acne care composition As a mask or facial cleanser, to cover large areas, the acne care composition demonstrates minimum resistance to spreading on the face, with good spreadability and remains in place without dripping. At low shear rate, the acne care composition behaves like yield stress fluid with a stable structure holding property, while at high shear rate, the shear stress exhibits an inflection point, followed by a sharp decrease in shear stress past peak while still at a high shear rate. Upon removal of sheer, the composition consistency returns to thick and paste like. [0034] The examples show that the acne care composition demonstrates peak shear stress in a range from about 200 to about 1000 PA at shear rate in the range from 1 1/s - 100 1/s, followed by a sharp drop in viscosity when shear stress is continued.
  • compositions [0036] Surfactant:
  • the acne care composition comprises the surfactant sodium cocoyl isethionate.
  • the acne care composition may include, or alternatively may be substantially free from, or exclude any one or more of nonionic, cationic, or anionic surfactants.
  • the acne care composition excludes all surfactants except sodium cocoyl isethionate.
  • the composition also includes at least one additional surfactant selected from glyceryl oleate, glyceryl stearate, and cetyl alcohol.
  • the composition includes at least glyceryl stearate SE in addition to sodium cocoyl isethionate.
  • the concentration of sodium cocoyl isethionate present in the acne care composition is from about 1% to about 20%, or from about 2% to about 18%, or from about 5% to about 15%, or from about 8% to about 12%, or about 10%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the acne care composition.
  • concentration of sodium cocoyl isethionate present in the acne care composition is from about 1% to about 20%, or from about 2% to about 18%, or from about 5% to about 15%, or from about 8% to about 12%, or about 10%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the acne care composition.
  • sodium cocoyl isethionate is present, by weight, based on the total weight of the acne care composition, from about 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17,18, 18 to about 20 weight percent, including increments and ranges therein and there between.
  • an additional surfactant for example, glyceryl stearate
  • an additional surfactant is present in the acne care composition is from about 1% to about 20%, or from about 2% to about 18%, or from about 5% to about 15%, or from about 8% to about 12%, or from about 2% to about 6%, or about 5%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the acne care composition.
  • an additional surfactant for example, glyceryl stearate
  • an additional surfactant when present, is present, by weight, based on the total weight of the acne care composition, from about 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17,18, 18 to about 20 weight percent, including increments and ranges therein and there between.
  • composition according to the invention comprises one or more glycolipids.
  • the at least one glycolipid is chosen from rhamnolipids, sophorolipids, or mixtures thereof.
  • the acne care composition includes only one glycolipid comprising rhamnolipid, for example sold under the name Rheance One (TM) by Evonik (INCI name : glycolipids), present from about 1% to about 4%, or from about 2% to about 3%, or about 3%.
  • TM glycolipid
  • Evonik Evonik
  • glycolipid is understood as meaning a compound formed from a lipid to which are attached one or more sugar compounds.
  • the one or more glycolipids may be selected from rhamnolipids, sophorolipids, glucolipids, trehalolipids, cellobiose lipids, mannosylerythritol lipid, and mixtures thereof.
  • the one or more glycolipids may be glucolipids, which contain a glucose moiety and can be represented by the general formula (I):
  • R1 represents a hydrogen atom or a cation
  • - q denotes an integer ranging from 4 to 10, preferably equal to 6.
  • the glucolipids can be produced by the bacterium Alcaligenes sp. MM1.
  • the one or more glycolipids may be sophorolipids, which contain a sophorose moiety and can be represented by the general formula (II):
  • R3 and R4 individually represent a hydrogen atom or an acetyl group
  • R5 represents a saturated or unsaturated, hydroxylated or non-hydroxylated hydrocarbon group having from 1 to 9 carbon atoms, preferably methyl,
  • R6 represents a saturated or unsaturated, hydroxylated or non-hydroxylated hydrocarbon group having from 1 to 19 carbon atoms, with the proviso that the total number of carbon atoms in the groups R5 and R6 does not exceed 20 and is preferably from 14 to 18.
  • Sophorolipids may be incorporated into the composition according to the invention either in the form of the open-chain free acid, where R7 represents a hydrogen atom and R8 represents a hydroxy group OH, or in its lactone form, where a lactone ring is formed between R7 and R8, as indicated by formula (III):
  • R3, R4, R5 and R6 are as defined above,
  • the sophorolipids can be produced by yeast cells, for example Torulopsis apicola and Torulopsis bombicola cells.
  • the fermentation process generally uses sugars and alkanes as substrates.
  • sophorolipids for example that sold under the Sopholiance S name by Givaudan and that sold under the BioToLife name by BASF.
  • the one or more glycolipids may be trehalolipids, which contain a trehalose fragment and can be represented by the general formula (IV):
  • R9, RIO and Rll individually represent a saturated or unsaturated, hydroxylated or nonhydroxylated hydrocarbon radical having from 5 to 13 carbon atoms.
  • the trehalolipids can be produced by bacterial fermentation using the marine bacterium Arthrobacter sp. Ek 1 or the freshwater bacterium Rhodococcus erythropolis.
  • Appropriate fermentation methods are provided by Ishigami et al. (1987), J. Jpn. Oil Chem. Soc., 36, 847-851, Schultz et al. (1991), Z. Naturforsch., 46C, 197-203, and Passeri et al. (1991), Z. Naturforsch., 46C,
  • the one or more glycolipids may be cellobiose lipids, which contain a cellobiose fragment and can be represented by the general formula (V):
  • R1 represents a hydrogen atom or a cation
  • R12 represents a saturated or unsaturated, hydroxylated or non-hydroxylated hydrocarbon radical having from 9 to 15 carbon atoms, preferably 13 carbon atoms, [0079] - R13 represents a hydrogen atom or a acetyl group;
  • R14 represents a saturated or unsaturated, hydroxylated or non-hydroxylated hydrocarbon radical having from 4 to 16 carbon atoms.
  • the cellobiose lipids can be produced by cells of fungi of the genus Ustilago. Appropriate fermentation processes are provided by Frautz, Lang and Wagner (1986), Biotech. Letts., 8, 757- 762.
  • the one or more glycolipids may be rhamnolipids.
  • composition according to the invention preferably comprises one or more rhamnolipids.
  • Rhamnolipids are glycolipids produced by various bacterial species. They consist of one rhamnose fragment (mono-rhamnolipid) or of two rhamnose fragments (di-rhamnolipid) linked by a glycosidic bond to one, two or three chains of [J-hydroxylated fatty acids linked to one another by an ester bond.
  • - n denotes an integer equal to 1 or 0, and [0090] - R1 and R2, each independently represent identical or different hydrocarbon radicals having from 2 to 24 carbon atoms, preferably from 5 to 13 carbon atoms, that are branched or unbranched, substituted or unsubstituted, in particular hydroxy-substituted, and saturated or unsaturated, preferably a singly, doubly or triply unsaturated alkyl radical.
  • composition according to the invention preferably comprises at least one dirhamnolipid.
  • composition according to the invention preferably comprises at least one dirhamnolipid of formula (VI) in which:
  • - m denotes an integer equal to 2, 1 or 0;
  • - n denotes an integer equal to 1
  • R1 and R2 each independently represent identical or different hydrocarbon radicals having from 2 to 24 carbon atoms, preferably from 5 to 13 carbon atoms, that are branched or unbranched, substituted or unsubstituted, in particular hydroxy-substituted, and saturated or unsaturated, preferably a singly, doubly or triply unsaturated alkyl radical, and also the salts thereof, solvates thereof and optical isomers thereof.
  • glycosidic bond between the two rhamnose fragments may be in the alpha or beta configuration and is preferably in the alpha configuration.
  • the salts of the di-rhamnolipids of formula (VI) are more particularly the carboxylate salts thereof with an organic or inorganic cation and especially with a cation selected from sodium, potassium, calcium and ammonium.
  • the solvated forms of the di-rhamnolipids of formula (VI) are more particularly those solvated with one or more molecules of water or of organic solvents, for example a hydrate or a solvate of a linear or branched alcohol, such as ethanol or isopropanol, the optically active carbon atoms of the fatty acids preferably being in the form of the R enantiomers, and
  • alkyl denotes a saturated, linear or branched aliphatic group; for example, a C1-C20 alkyl group having a linear or branched hydrocarbon chain of 1 to 20 carbon atoms, more particularly a methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, do
  • composition according to the invention preferably comprises at least one dirhamnolipid of formula (VI) in which:
  • - m denotes an integer equal to 2, 1 or 0;
  • - n denotes an integer equal to 1
  • R1 and R2 which are identical or different, are selected from pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl and tridecenyl radicals and radicals of formula -(CH2)oCH3, with o denoting an integer ranging from 1 to 23, in particular from 3 to 15 and more particularly from 4 to 12.
  • the composition according to the invention comprises at least one di-rhamnolipids of general formula (VI) in which m is equal to 1 [00107] According to one embodiment of the invention, the composition according to the invention comprises a mixture of at least two, preferably at least three, di-rhamnolipids of general formula (VI) in which m is preferably equal to 1.
  • the composition according to the invention comprises a mixture comprising at least one mono-rhamnolipid.
  • composition according to the invention comprises at least one dirhamnolipid of the following formula (VII):
  • - m denotes an integer equal to 2, 1 or 0; preferably, m is equal to 1,
  • - R1 is a -(CH2)p-CH3 radical, with p being an integer varying from 1 to 23, preferably from 4 to 12,
  • - R2 is a -(CH2)q-CH3 radical, with q being an integer varying from 1 to 23, preferably from 4 to 12,
  • di-RL-CXCY is an alternative way of writing in order to represent a dirhamnolipid (di-RL) functionalized by two radicals R1 and R2 respectively represented by the symbols CX and CY, the integers X and Y being respectively equal to p+4 and q+4.
  • the composition according to the invention comprises at least one di-rhamnolipid of formula (VII) in which p and q are identical and equal to 6 and m is equal to 1, also referred to as di-RL-ClOClO, or one of the salts, solvates and optical isomers thereof.
  • VI di-rhamnolipid of formula (VII) in which p and q are identical and equal to 6 and m is equal to 1, also referred to as di-RL-ClOClO, or one of the salts, solvates and optical isomers thereof.
  • the di-rhamnolipid of formula (VII) in which p and q are identical and equal to 6 and m is equal to 1 is present in the composition according to the invention in a proportion of at least 50% by weight and preferably of from 51% to 85% by weight, relative to the total weight of rhamnolipids.
  • the composition according to the invention comprises at least one di-rhamnolipid of formula (VII) in which m is equal to 1, p is equal to 6 and q is equal to 8.
  • the composition according to the invention comprises at least one di-rhamnolipid of formula(VI) in which n and m are equal to 1, R1 represents a -(CH2)oCH3 radical, with o being an integer varying from 4 to 12, and R2 is selected from the pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl and tridecenyl radicals; preferably, R1 represents a -(CH2)6CH3 radical and R2 a nonenyl radical.
  • the composition according to the invention comprises a mixture of at least two, in particular at least three, di-rhamnolipids of formula (VI) or of formula (VII) selected from:
  • R1 represents a -(CH2)oCH3 radical, with o being an integer varying from 4 to 12
  • R2 is selected from the pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl and tridecenyl radicals; preferably, R1 represents a -(CH2)6CH3 radical and R2 a nonenyl radical.
  • the composition according to the invention comprises a mixture of at least two, in particular at least three, di-rhamnolipids of formula (VI) or of formula (VII) selected from: [00128] -at least 50% by weight and preferably of from 51% to 85% by weight of a di- rhamnolipid of formula (VII) in which p and q are identical and equal to 6 and m is equal to 1, relative to the total weight of rhamnolipids.
  • [00130] from 0.5% to 15% by weight, preferably from 3% to 12% by weight, preferably from
  • R1 represents a -(CH2)6CH3 radical and R2 represents a nonenyl radical, relative to the total weight of rhamnolipids.
  • rhamnolipids are customarily prepared by processes known to those skilled in the art starting from bacterial producers, such as Pseudomonas.
  • the concentration of the at least one glycolipid is from about 0.1% to about 5%, or from about 1% to about 4%, or from about 2% to about 3%, or about 3%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the acne care composition.
  • concentration of the at least one glycolipid is from about 0.1% to about 5%, or from about 1% to about 4%, or from about 2% to about 3%, or about 3%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the acne care composition.
  • the at least one glycolipid is present, by weight, based on the total weight of the acne care composition, from about 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 3.8, 3.9, 4.0, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9 to about 5 weight percent, including increments and ranges therein and there between.
  • the acne care composition comprises at least one beta hydroxy acid.
  • the acne care composition may include a beta hydroxy acid comprising salicylic acid.
  • the acne care composition includes only one beta hydroxy acid comprising salicylic acid present from about 0.1% to about 2%, by weight of the acne care composition.
  • the composition according to the present invention comprises (b) at least one salicylic acid derivative according to formula (I).
  • a single type of the salicylic acid derivative may be used, but two or more different types of the salicylic acid derivatives may be used in combination.
  • the radical R denotes a linear, branched or cyclic, saturated aliphatic chain containing from 2 to 22 carbon atoms; an unsaturated chain containing from 2 to 22 carbon atoms containing one or more double bonds that may be conjugated; an aromatic nucleus linked to the carbonyl radical directly or via saturated or unsaturated aliphatic chains containing from 2 to 7 carbon atoms; said groups possibly being substituted with one or more substituents, which may be identical or different, chosen from halogen atoms, a trifluoromethyl group, hydroxyl groups in free form or esterified with an acid containing from 1 to 6 carbon atoms, or carboxyl groups in free form or esterified with a lower alcohol containing from 1 to 6 carbon atoms;
  • R' is a hydroxyl group or an ester group of formula:
  • Ri denotes a linear or branched, saturated or unsaturated aliphatic chain containing 1 to 18 carbon atoms
  • the R radical in formula (I) denotes a linear, branched or cyclic, saturated aliphatic chain containing from 3 to 11 carbon atoms; an unsaturated chain containing from 3 to 17 carbon atoms and comprising one or more conjugated or unconjugated double bonds; it being possible for said hydrocarbon-based chains to be substituted with one or more substituents, which may be identical or different, chosen from halogen atoms, a trifluoromethyl group, hydroxyl groups in free form or esterified with an acid containing from 1 to 6 carbon atoms, or a carboxyl function in free form or esterified with a lower alcohol containing from 1 to 6 carbon atoms.
  • the R radical in formula (I) denotes a linear or branched alkyl or alkenyl group, preferably alkyl group, containing 2 or more, preferably 3 or more, more preferably 4 or more, even more preferably 5 or more, and in particular 6 or more carbon atoms, and/or 22 or less, preferably 18 or less, even more preferably 14 or less, preferentially 12 or less, and in particular 10 or less carbon atoms.
  • R' in formula (I) is a hydroxyl group or an ester group of formula:
  • Ri denotes a radical -(CHzJn-CHs where n is a number ranging from 0 to 14.
  • the salicylic acid derivatives that are more particularly preferred are those according to formula (I) in which the R radical is a C3-C10 alkyl group and/or R’ denotes hydroxyl.
  • R represents a chain derived from caprylic, linoleic, linolenic or oleic acid.
  • R radical denotes a C3-C10 alkyl group bearing a carboxyl function in free form or esterified with a lower alcohol containing from 1 to 6 carbon atoms and R’ denotes hydroxyl.
  • salicylic acid derivatives of formula (I) include 5-n-octanoylsalicylic acid (or capryloyl salicylic acid); 5-n-decanoylsalicylic acid; 5-n- dodecanoylsalicylic acid; 5-n-heptyloxysalicylic acid, and the corresponding salts thereof.
  • the derivative in question is preferably 5-n-octanoylsalicylic acid.
  • the salts of the salicylic acid derivatives are also considered.
  • salts derived from inorganic bases mention may particularly be made of those derived from alkali metal or alkaline-earth metal hydroxylated bases, for instance sodium hydroxide or potassium hydroxide, and ammonia.
  • salts derived from the organic bases mention may particularly be made of those derived from bases of amine or alkanolamine type.
  • beta-hydroxy acid is understood to mean, according to the present invention, a carboxylic acid having a hydroxyl functional group and a carboxylic functional group separated by two carbon atoms.
  • a beta hydroxy acid can be present in the acne care composition in the form of the free acid and/or in the form of one of its associated salts (salts with an organic base or an alkali metal, in particular), especially according to the final pH imposed on acne care composition.
  • Suitable beta hydroxy acids include salicylic acid and derivatives thereof (including 5- n-octanoylsalicylic acid, salicylate, sodium salicylate, and willow extract), capryloyl salicylic acid, beta hydroxybutanoic acid, propionic acid, beta-hydroxy beata-methylbutyric acid, carnitine tropic acid, and trethocanic acid, and combinations of these.
  • the acne care composition includes a concentration of beta hydroxy acid in a range from about 0.01% up to and not more than about 2% of beta hydroxy acid, by weight, based on the total weight of acne care composition.
  • the acne care composition may include up to and not more than about 2%, or about 1.9% of beta hydroxy acid.
  • the acne care composition may include up to and not more than about 1% of beta hydroxy acid.
  • the amount of beta hydroxy acid, if present is not more than about 0.40% to about 0.50%.
  • the acne care composition may include from about 0.1% to about 2% of beta hydroxy acid, or any suitable combination, sub-combination, range, or subrange thereof by weight, based on the weight of the acne care composition.
  • beta hydroxy acid any suitable combination, sub-combination, range, or subrange thereof by weight, based on the weight of the acne care composition.
  • the at least one beta hydroxy acid is present in the acne care composition from about 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, to about 2.0%, by weight, based on the weight of the acne care composition, including increments and all ranges and subranges therein and there between.
  • the acne care composition may include at least one clay.
  • the at least one clay is kaolin present from about 5% to about 20%, by weight of the acne care composition.
  • the at least one clay may be selected from the group of clays consisting of kaolinites, smectite, sodium smectite, calcium smectite, illite, chlorite, vermiculite, attapulgite, and combinations thereof.
  • the at least one clay may be kaolin.
  • the at least one clay may be a smectite clay in the mica family of phylosilicates.
  • the at least one clay may comprise hectorite.
  • the at least one clay is present in an amount from about 0.1% to about 20%, or from about 10% to about 18%, or about 15%, or any suitable combination, subcombination, range, or sub-range thereof by weight, based on the weight of the acne care composition.
  • the acne care composition when at least one clay is present in the acne care composition it may be present by weight, based on the total weight of the acne care composition, from about 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, to about 20 percent, including increments and ranges therein and there between.
  • compositions according to the disclosure contain at least one cosmetically acceptable solvent.
  • the cosmetically acceptable solvent may be chosen from water.
  • Water [00171]
  • water is present in the acne care composition in a range from about 10% to about 60%, or from about 20% to about 55%, or from about 25% to about 50%, or from about 28% to about 49%, or any suitable combination, subcombination, range, or sub-range thereof by weight, based on the weight of the acne care composition.
  • water is present in the acne care composition in a range from about 10% to about 60%, or from about 20% to about 55%, or from about 25% to about 50%, or from about 28% to about 49%, or any suitable combination, subcombination, range, or sub-range thereof by weight, based on the weight of the acne care composition.
  • water may be present by weight, based on the weight of the acne care composition, from about 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, to about 60 weight percent, including increments and ranges therein and there between.
  • the water used may be sterile demineralized water and/or a floral water such as rose water, cornflower water, chamomile water or lime water, and/or a natural thermal or mineral water such as, for example: water from Vittel, water from the Vichy basin, water from Uriage, water from La Roche Posay, water from La Bourboule, water from Enghien-les-Bains, water from Saint Gervais-les-Bains, water from Neris-les-Bains, water from Allevar-les-Bains, water from Digne, water from Maizieres, water from Neyrac-les-Bains, water from Lons-le-Saunier, water from Eaux Bonnes, water from Rochefort, water from Saint Christau, water from Les Fumades, water from Tercis-les-Bains or water from Avene.
  • a floral water such as rose water, cornflower water, chamomile water or lime water
  • a natural thermal or mineral water such as, for example: water from Vittel, water from the Vi
  • the water phase may also comprise reconstituted thermal water, that is to say a water comprising trace elements such as zinc, copper, magnesium, etc., reconstituting the characteristics of a thermal water.
  • the acne care composition has a pH 4.7 - 5.9.
  • the pH may be adjusted to the desired value by addition of a base (organic or inorganic), for example sodium hydroxide, potassium hydroxide, or another suitable base, or combinations thereof.
  • a base organic or inorganic
  • sodium hydroxide for example sodium hydroxide, potassium hydroxide, or another suitable base, or combinations thereof.
  • the acne care composition includes at least one water-soluble solvent.
  • water-soluble solvent is interchangeable with the term “water-miscible solvent” and means a compound that is liquid at 25 °C and at atmospheric pressure (760 mmHg), and it has a solubility of at least 50% in water under these conditions.
  • the water-soluble solvent has a solubility of at least 60%, 70%, 80%, or 90% in water under these conditions.
  • the water-soluble solvent includes glycerin present from about 5% to about 30%, or from about 10% to about 30%, by weight of the acne care composition.
  • organic solvents non-limiting mentions can be made of ethyl alcohol, isopropyl alcohol, propyl alcohol, benzyl alcohol, and phenylethyl alcohol, or glycols or glycol ethers such as, for example, monomethyl, monoethyl and monobutyl ethers of ethylene glycol, propylene glycol or ethers thereof such as, for example, monomethyl ether of propylene glycol, butylene glycol, hexylene glycol, dipropylene glycol as well as alkyl ethers of diethylene glycol, for example monoethyl ether or monobutyl ether of diethylene glycol.
  • glycols or glycol ethers such as, for example, monomethyl, monoethyl and monobutyl ethers of ethylene glycol, propylene glycol or ethers thereof such as, for example, monomethyl ether of propylene glycol, butylene glycol, hexylene glycol, dipropylene glyco
  • organic solvents are ethylene glycol, propylene glycol, butylene glycol, hexylene glycol, propane diol, and glycerin.
  • the organic solvents can be volatile or non-volatile compounds.
  • water-soluble solvents include alkanols (polyhydric alcohols, glycols and polyols) such as glycerin, 1,2,6-hexanetriol, trimethylolpropane, ethylene glycol, propylene glycol, diethylene glycol, butylene glycol, hexylene glycol, triethylene glycol, tetraethylene glycol, pentaethylene glycol, dipropylene glycol, 1,3-butanediol, 2,3-butanediol,
  • water-soluble solvents include alkyl alcohols having 1 to 4 carbon atoms such as ethanol, methanol, butanol, propanol, and isopropanol; glycol ethers such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, ethylene glycol monomethyl ether acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol mono-n-propyl ether, ethylene glycol mono-iso-propyl ether, diethylene glycol mono-iso-propyl ether, ethylene glycol mono-n-butyl ether, ethylene glycol mono-t-butyl ether, diethylene glycol mono-t-butyl ether, 1-methyl-l- methoxybutanol, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol, and isopropanol;
  • the amount of the at least one water- soluble solvent is from about 0.1% to about 25%, or from about 0.1% to about 2%, or from about 0.1% to about 1%, or from about 0.1% to about 0.8%, or from about 0.1% to about 0.5%, or from about 1% to about 20%, or from about 1% to about 10%, or from about 2% to about 8%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the acne care composition.
  • One of ordinary skill in the art will appreciate that other ranges are within the scope of the invention.
  • the acne care composition includes more than one water soluble solvent, each water soluble solvent present in an amount as set forth herein above, wherein each different water soluble solvent may be present within one of the ranges selected from the ranges set forth herein above.
  • water-soluble solvents may be present by weight, based on the total weight of the acne care composition, from about 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 to about 25 weight percent, including increments and ranges therein and there between.
  • Thickener 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 to about 25 weight percent, including increments and ranges therein and there between.
  • the acne care composition may comprise at least one stabilizer and/or thickening agent (thickener).
  • the thickener may be thickening polymers.
  • thickening polymers include sclerotium gum, xanthan gum, carrageenan, acacia, agar, algin, alginic acid, ammonium alginate, amylopectin, calcium alginate, sodium alginate, calcium carrageenan, carnitine, carrageenan, dextrin, gelatin, gellan gum, guar gum, tragacanth gum, acacia gum, Arabic gum, guar hydroxypropyltrimonium chloride, hectorite, hyaluronic acid, hydrated silica, hydroxypropyl chitosan, hydroxypropyl guar, karaya gum, kelp, locust bean gum, natto gum, potassium alginate, potassium carrageenan, propylene glyco
  • the acne care composition comprises one or more of carrageenan, xanthan gum, and sclerotium gum, or a combination thereof, present in a range from about 0.1% to about 5%, or at about 1%, by weight of the acne care composition.
  • the acne care composition comprises carrageenan as a particularly preferred stabilizer/thickening agent, present at about 1%, by weight of the acne care composition.
  • the at least one thickener when present, is present in the acne care composition from about 0.1% to about 5%, or from about 0.2% to about 3%, or from about 0.5% to about 2%, or about 1%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the acne care composition.
  • any suitable combination, sub-combination, range, or sub-range thereof by weight based on the weight of the acne care composition.
  • the at least one thickener may be present, by weight, based on the total weight of the acne care composition, from about 0.05, 0.06, 0.07, 0.08, 0.90, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 2, 3, 4 to about 5 weight percent, including increments and ranges therein and there between.
  • the acne care composition may comprise at least one cationic polymer selected from nature-based polymers that are polysaccharides, and other natural (i.e., plant, animal, or bacterial based), synthetic, or modified cationic nature-based or synthetic polymers.
  • the cationic polymer is a nature-based polymer.
  • a cationic nature-based polymer may be selected from cationic forms and cationic derivatives of polysaccharides isolated from algae, polysaccharides produced by microorganisms, and polysaccharides from higher plants, such as homogeneous polysaccharides.
  • the acne care composition comprises the at least one naturebased cationic polymer comprising chitosan, where in some embodiments chitosan is selected from chitosan oligosaccharide, chitosan (or polymeric chitosan having molecular weight (MW) in a range from about 1 kDa to about 1000 kDa), derivatives of chitosan, including derivatives having enhanced solubility, or combinations thereof.
  • chitosan is selected from chitosan oligosaccharide, chitosan (or polymeric chitosan having molecular weight (MW) in a range from about 1 kDa to about 1000 kDa), derivatives of chitosan, including derivatives having enhanced solubility, or combinations thereof.
  • the acne care composition comprises chitosan present at about 0.1%, by weight of the acne care composition.
  • cationic nature-based polymer selected from polysaccharides may be chosen from polysaccharides that include chitosan, chitin, starches, alginates, celluloses, galactomannans such as guar gums, particularly cationic derivatives thereof, and combinations thereof.
  • the at least one cationic nature-based polymer selected from polysaccharides may be chosen from chitosan, chitosan derivatives, chitin, starch, starch derivatives, cellulose (for example, but not limited to, ethylcellulose, nitrocellulose, hemicellulose, and hemicellulose derivatives), alginates, including but not limited to, sodium alginate, and combinations thereof.
  • the cationic polymer is a nature-based cationic polymer selected from: chitosan, chitosan oligosaccharide, polymeric chitosan having MW in a range from 1 kDa to about 1000 kDa, derivatives of chitosan, derivatives of chitosan having enhanced solubility, cyclodextrin, cationic gelatin, cationic dextran, cationic cellulose, polylysine, polyornithine, histone, collagen, chitosan-cysteine, chitosan-thiobutylamidine, chitosan- thioglycolic acid, or combinations thereof.
  • the cationic polymer is selected from chitosan, polylysine, or combinations thereof.
  • cationic polymers include polysaccharide-based delivery molecules (e.g., chitosan, cyclodextrin, cationic gelatin, cationic dextran, cationic cellulose), cationic peptides and their derivatives (e.g., polylysine, polyornithine), peptide/protein polymers ((e.g., histone, collagen), linear or branched synthetic polymers (e.g., polybrene, polyethyleneimine), natural polymers (e.g., histone, collagen), synthetic dendrimers, cationic thiolated biopolymers (naturebased thiomers or nature-based dendrimers, e.g., chitosan-cysteine, chitosan-thiobutylamidine as well as chitosan-thioglycolic acid).
  • polysaccharide-based delivery molecules e.g., chitosan, cyclodextrin, cationic
  • nature-based cationic polymers include polysaccharide-based delivery molecules (e.g., chitosan, cyclodextrin, cationic gelatin, cationic dextran, cationic cellulose); cationic peptides and their derivatives (e.g., polylysine, polyornithine), peptide/protein polymers (e.g., histone, collagen); cationic thiolated biopolymers (nature-based thiomers or nature-based dendrimers, e.g., chitosan-cysteine, chitosan-thiobutylamidine, chitosan-thioglycolic acid); or combinations thereof.
  • polysaccharide-based delivery molecules e.g., chitosan, cyclodextrin, cationic gelatin, cationic dextran, cationic cellulose
  • cationic peptides and their derivatives e.g., polylysine,
  • the cationic polymer may be selected from polylysines.
  • a single type of polylysines may be used, or two or more different types of polylysines may be used in combination.
  • Polylysines correspond to the condensation of several amino acids of lysine.
  • Polylysine can be a natural homopolymer of L-lysine that can be produced by bacterial fermentation. Polylysines are typically used as a natural preservative in food products. Polylysine is a polyelectrolyte which is soluble in polar solvents such as water.
  • Polylysine can be, for example, epsilon-polylysine (or referred as "s-polylysine”), which is a condensation of amino groups at the s-position and carboxyl groups of lysines, or alpha-polylysine (or referred as "a-polylysine”), which is a condensation of amino groups at the a-position and carboxyl groups of lysines.
  • Polylysine is commercially available in various forms, such as poly D-lysine and poly L-lysine.
  • the polylysine is generally a condensate of L-lysines, i.e., poly L-lysine.
  • polylysine As an example of polylysine, mention may be made of:
  • L-lysine having a molecular weight of around 4,700 in aqueous solution.
  • the polylysine may be in the form of organic or inorganic salts.
  • the addition salts with an acid are, for example, the hydrochloric or hydrobromic acid, sulfuric acid, citric acid, succinic acid, tartaric acid, lactic acid, para-toluenesulphonic acid, phosphoric acid, or acetic acid salts; or fatty acid salts, such as linoleic acid, oleic acid, palmitic acid, stearic acid, behenic acid, and 18- methylicosanoic acid.
  • the addition salts with a base are, for example, a sodium salt, a calcium salt, or a hydroxyalkylamine salt, for example, N-methylglucamine, aminopropane diol or triethanolamine.
  • polylysine is in the free form.
  • free form here indicates that the polylysine is not covalently bound to any other compounds.
  • the at least one cationic polymer when present, is present in the acne care composition from about 0.05% to about 2%, or from about 0.05% to about 1%, or from about 0.05% to about 0.5%, or about 0.1%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the acne care composition.
  • a suitable combination, sub-combination, range, or sub-range thereof by weight based on the weight of the acne care composition.
  • the at least one cationic polymer may be present, by weight, based on the total weight of the acne care composition, from about 0.05, 0.06, 0.07, 0.08, 0.90, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, to about 2 weight percent, including increments and ranges therein and there between.
  • the acne care composition may include or exclude any other cationic polymer, including a nature-based polymer or synthetic polymer.
  • the synthetic polymers are non-silicone based, and in some embodiments may be selected from the group consisting of polyquaterniums, that is polymers having quaternary ammonium centers in the polymer, for example, including polyquaternium-47 (1-Propanaminium, N,N,N-trimethyl-3-[(2-methyl-l-oxo-2-propenyl)amino]-, chloride, polymer with methyl 2-propenoate and 2-propenoic acid).
  • polyquaterniums that is polymers having quaternary ammonium centers in the polymer, for example, including polyquaternium-47 (1-Propanaminium, N,N,N-trimethyl-3-[(2-methyl-l-oxo-2-propenyl)amino]-, chloride, polymer with methyl 2-propenoate and 2-propenoic acid).
  • polyquaternium compounds may be selected from diallyidimethylammonium chloride/acrylic acid copolymers sold under the names MERQUAT 280 POLYMER or MERQUAT 280NP POLYMER or MERQUAT 281 POLYMER or MERQUAT 295 POLYMER, by the company Nalco (Lubrizol) (INCI name: Polyquaternium-22); the copolymer of methacrylamidopropyltrimonium chloride, of acrylic acid and or methyl acrylate, sold under the name MERQUAT 2001 POLYMER OR MERQUAT 2001N POLYMER by the company Nalco (Lubrizol) (INCI name: Polyquaternium-47); the acrylamide/dimethyldiallylammonium chloride/acrylic acid terpolymer sold under the name MERQUAT 3330DRY POLYMER or MERQUAT 3330PR POLYMER or MERQUAT 3331PR POLYMER or MERQUAT 3940 PO
  • polyquaternium compounds may be selected from Polyquaternium-30, Polyquaternium-35, Polyquaternium-45, Polyquaternium-50, Polyquaternium-54; Polyquaternium-57; Polyquaternium-63; Polyquaternium-74;
  • Synthetic polymer may include cationic acrylic polymers, for example, an amorphous functional acrylic polymer grafted onto a polyethylene backbone such as SYNTRAN (TM) 5330, which is a quaternary modified olefin grafted technology.
  • TM amorphous functional acrylic polymer grafted onto a polyethylene backbone
  • Synthetic polymers may be selected from, polyacrylates such as those identified in the International Cosmetic Ingredient Dictionary and Handbook (9 th ed. 2002) such as, for example, polyacrylate-1, polyacrylate-2, polyacrylate-3, polyacrylate-4, polyacrylate-16, polyacrylate-17, polyacrylate-18, polyacrylate-19, polyacrylate-21, and mixtures thereof.
  • additives there may be one or more optional actives or other ingredients (herein, "additives") present in the acne care composition, the one or more additives optionally selected from: anti-microbials; chelating agents; oils; fillers; penetrants; sequestrants; fragrances; dispersants; skin care actives such as ceramides, for example, SODIUM LAUROYL LACTYLATE (and) CERAMIDE NP (and) CERAMIDE AP (and) PHYTOSPHINGOSINE (and) CHOLESTEROL (and) XANTHAN GUM (and) CARBOMER (and) CERAMIDE EOP; opacifiers; alphahydroxy acids; organic and inorganic UV filters; citric acid; phenylethyl resorcinol; hydroxypropyl tetrahydropyrantriol; hydroxyacetophenone; antioxidants, including, but not limited to, phenolic compounds, such as chaicones, flavones
  • the acne care composition includes at least one additive selected from the group consisting of sodium hydroxide, niacinamide, lactic acid, cetyl alcohol, trisodium ethylenediamine disuccinate, ceramides, and a combination thereof.
  • the acne care composition includes additives comprising sodium hydroxide (0.3-0.5%), niacinamide (2%), lactic acid (0.05%), cetyl alcohol (2.5%), trisodium ethylenediamine disuccinate (0.5-1%), and ceramides (sodium lauroyl lactylate (and) ceramide NP (and) ceramide AP (and) phytosphingosine (and) cholesterol (and) xanthan gum (and) carbomer (and) ceramide EOP) (*fina I active concentration 0.25%)).
  • the amounts of additives, for example, actives and other components, that may be present in the acne care composition can range from about 0.001% to about 50%, or from about 0.5% to about 30%, or from about 1.5% to about 20%, and from about 5% to about 15%, or any suitable combination, sub-combination, range, or subrange thereof by weight, based on the weight of the acne care composition.
  • one or a combination of additives may be present in the acne care composition, by weight, based on the weight of the acne care composition, each one or the combination present from about 0.001, 0.002, 0.003, 0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.10, 0.20, 0.30, 0.40, 0.50, 0.60, 0.70, 0 0.80, 0.90, 1.0, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 to about 50 weight percent, including increments and ranges therein and there between.
  • Percentages of each ingredient as may be exemplified in the following composition examples are shown as amount of raw materials, wherein the raw materials may be present in an amount that is equal to the amount of active, or if the raw material has a concentration of active that is less than 100%, then the cosmetic composition includes the raw material that includes active and a suitable solvent, wherein the concentration of active in the raw material is provided herein below in Table 2.
  • the concentration of active in the raw material is provided herein below in Table 2.
  • Example 2 Inventive and Comparative Compositions
  • Table 3 includes inventive compositions A and B.
  • inventive and comparative compositions in Table 4, below, include the same ingredients as one of Inventive A or B but either lack or have a substituted ingredient.
  • Sample viscosity flow profile was measured by rheometer in flow sweep mode between shear rate of 0.01 1/s and 1000 1/s. Prior to the measurement, sample was conditioned at 25 C, and allowed to perform preshear then equilibration.
  • FIG. 1 shows the change in viscosity in all tested compositions under study
  • FIG. 2 and FIG. 3, respectively, show the behavior of the tested compositions when a high shear is applied.
  • the presence of peak shear stress is independent of polymer and concentration of glycerin, but relates to the presence of sodium cocoyl isethionate surfactant.
  • the phrases “and mixtures thereof,” “and a mixture thereof,” “and combinations thereof,” “and a combination thereof,” “or mixtures thereof,” “or combinations thereof,” and “or a combination thereof,” are used interchangeably to denote that the listing of components immediately preceding the phrase, such as "A, B, C, D, or mixtures thereof” signify that the component(s) may be chosen from A, from B, from C, from D, from A+B, from A+B+C, from A+D, from A+C+D, etc., without limitation on the variations thereof. Thus, the components may be used individually or in any combination thereof.
  • a range given of "about 3% to 7%” is intended to have the term “about” modifying both the 3% and the 7% endpoints.
  • the term “about” is used herein to indicate a difference of up to +/- 10% from the stated number, such as +/- 9%, +/- 8%, +/- 7%, +/- 6%, +/- 5%, +/- 4%, +/- 3%, +/- 2%, or +/- 1%-
  • all endpoints of ranges are understood to be individually disclosed, such that, for example, a range of 1:2 to 2:1 is understood to disclose a ratio of both 1:2 and 2:1.
  • Active material as used herein with respect to the percent amount of an ingredient or raw material, refers to 100% activity of the ingredient in the raw material except as specifically stated. All amounts given herein are relative to the amount of active material, unless otherwise indicated.
  • surfactants as well as any specifically identified surfactants, includes salts of the surfactants even if not explicitly stated.
  • synthetic means a material that is not of natural origin.
  • natural and naturally-sourced and “nature-based” means a material of natural origin, such as derived from plants, which also cannot be subsequently chemically or physically modified.
  • Plant-based means that the material came from a plant.
  • the term "substantially free” or “essentially free” as used herein means the specific material may be present in small amounts that do not materially affect the basic and novel characteristics of the embodiments of the composition according to the disclosure or the material may be absent. For instance, there may be less than 2% by weight of a specific material added to a composition, based on the total weight of the compositions (provided that an amount of less than 2% by weight does not materially affect the basic and novel characteristics of embodiments of the composition according to the disclosure. Similarly, the compositions may include less than 2%, less than 1.5%, less than 1%, less than 0.5%, less than 0.1%, less than 0.05%, or less than 0.01%, or none (0%) of the specified material.
  • a claimed composition may be “free,” “essentially free” (or “substantially free”) of one or more components that are positively set forth in the instant disclosure.
  • the term “substantially free” or “essentially free” as used herein may also mean that the specific material is not added to the composition but may still be present in a raw material that is included in the composition.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

Une composition pour le soin de l'acné comprend au moins un tensioactif comprenant du cocoyle iséthionate de sodium et éventuellement du stéarate de glycéryle SE, au moins un glycolipide, au moins un bêta-hydroxyacide comprenant de l'acide salicylique ou un dérivé associé, au moins une argile comprenant éventuellement du kaolin, au moins un polymère cationique comprenant éventuellement du chitosane, au moins un épaississant comprenant un élément parmi le carraghénane, la gomme xanthane, la gomme de sclérotium ou une combinaison associée, au moins un solvant cosmétiquement acceptable comprenant de l'eau et comprenant de la glycérine, et au moins un additif choisi dans le groupe constitué par l'hydroxyde de sodium, le niacinamide, l'acide lactique, l'alcool cétylique, le disuccinate d'éthylènediamine trisodique, les céramides et des combinaisons associées. Lorsqu'elle est appliquée sur la peau par frottement, la composition présente une contrainte de cisaillement de pic dans une plage d'environ 100 à environ 1 000 PA à une vitesse de cisaillement dans la plage de 1 1/s à 100 1/s, suivie d'une chute nette de viscosité lorsque la contrainte de cisaillement est maintenue.
PCT/IB2025/051414 2024-02-29 2025-02-11 Composition cosmétique pour le soin de l'acné Pending WO2025181601A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18/591,930 US20250275908A1 (en) 2024-02-29 2024-02-29 Cosmetic composition for acne care
US18/591,930 2024-02-29
FRFR2404520 2024-04-30
FR2404520A FR3161561A3 (fr) 2024-04-30 2024-04-30 Composition cosmétique pour le soin de l’acné

Publications (1)

Publication Number Publication Date
WO2025181601A1 true WO2025181601A1 (fr) 2025-09-04

Family

ID=94637513

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2025/051414 Pending WO2025181601A1 (fr) 2024-02-29 2025-02-11 Composition cosmétique pour le soin de l'acné

Country Status (1)

Country Link
WO (1) WO2025181601A1 (fr)

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2581542A1 (fr) 1985-05-07 1986-11-14 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
EP0378936A2 (fr) 1988-12-16 1990-07-25 L'oreal Utilisation de dérivés salicylés pour le traitement du vieillissement de la peau
EP0570230A1 (fr) 1992-05-15 1993-11-18 Shiseido Company Limited Préparation externe pour la peau
US5267407A (en) 1990-04-18 1993-12-07 Forjas Taurus S/A Safety device for semiautomatic pistol
US5558871A (en) 1994-01-10 1996-09-24 L'oreal Cosmetic and/or dermatological compositions containing salicylic acid
US5667789A (en) 1994-11-03 1997-09-16 L'oreal Salicylic acid derivative as a stabilizer for an oil-in-water emulsion
US6159479A (en) 1997-09-16 2000-12-12 L'oreal Hydrous salicylic acid solutions
FR3114504A1 (fr) * 2020-09-25 2022-04-01 L'oreal Composition comprenant un glycolipide et un dÉrivÉ d’acide salicyclique
WO2022162620A2 (fr) * 2021-01-29 2022-08-04 L'oreal Composition de nettoyant assurant un dépôt amélioré d'acide salicylique pour le traitement de l'acné
CN116370349A (zh) * 2023-04-17 2023-07-04 深圳市理然化妆品有限公司 一种氨基酸洗面奶及其制备方法应用
WO2023150149A1 (fr) * 2022-02-02 2023-08-10 Locus Solutions Ipco, Llc Dérivés de sophorolipides améliorés avec des cargos d'agent thérapeutique et leur utilisation

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767750A (en) 1985-05-07 1988-08-30 L'oreal Topical compositions intended for skin treatment containing salicylic acid derivatives
FR2581542A1 (fr) 1985-05-07 1986-11-14 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
EP0378936A2 (fr) 1988-12-16 1990-07-25 L'oreal Utilisation de dérivés salicylés pour le traitement du vieillissement de la peau
US5267407A (en) 1990-04-18 1993-12-07 Forjas Taurus S/A Safety device for semiautomatic pistol
US5580549A (en) 1992-05-15 1996-12-03 Shiseido Co., Ltd. External preparation for skin
EP0570230A1 (fr) 1992-05-15 1993-11-18 Shiseido Company Limited Préparation externe pour la peau
US5558871A (en) 1994-01-10 1996-09-24 L'oreal Cosmetic and/or dermatological compositions containing salicylic acid
US5667789A (en) 1994-11-03 1997-09-16 L'oreal Salicylic acid derivative as a stabilizer for an oil-in-water emulsion
US6159479A (en) 1997-09-16 2000-12-12 L'oreal Hydrous salicylic acid solutions
FR3114504A1 (fr) * 2020-09-25 2022-04-01 L'oreal Composition comprenant un glycolipide et un dÉrivÉ d’acide salicyclique
WO2022162620A2 (fr) * 2021-01-29 2022-08-04 L'oreal Composition de nettoyant assurant un dépôt amélioré d'acide salicylique pour le traitement de l'acné
WO2023150149A1 (fr) * 2022-02-02 2023-08-10 Locus Solutions Ipco, Llc Dérivés de sophorolipides améliorés avec des cargos d'agent thérapeutique et leur utilisation
CN116370349A (zh) * 2023-04-17 2023-07-04 深圳市理然化妆品有限公司 一种氨基酸洗面奶及其制备方法应用

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
A.P. TULLOCHJ.F.T. SPENCERP.A.J. GORIN, CAN. J. CHEM., vol. 40, 1962, pages 1326
D. HAFERBURGR. HOMMELR. CLAUSH.P. KLEBER, ADV. BIOCHEM. ING./BIOTECHNOL., vol. 33, 1986, pages 53 - 90
F. WAGNERH. BOCKA. KRETSCHMAR: "Fermentation", 1981, SPRINGER VERLAG, pages: 181 - 192
FRAUTZ, LANGWAGNER, BIOTECH. LETTS, vol. 8, 1986, pages 757 - 762
ISHIGAMI ET AL., J. JPN. OIL CHEM. SOC., vol. 36, 1987, pages 847 - 851
M. SCHMIDT, TECHNICAL UNIVERSITY OF BRAUNSCHWEIG, 1990
PASSERI ET AL., Z. NATURFORSCH., vol. 46C, 1991, pages 204 - 209
U. GOBBERTS. LANGF. WAGNER, BIOTECHNOLOGY LETTERS, vol. 6, no. 4, 1984, pages 225

Similar Documents

Publication Publication Date Title
US20220316073A1 (en) Method for inhibiting metal corrosion during acid cleaning or pickling
US20250275908A1 (en) Cosmetic composition for acne care
CN104611150B (zh) 一种含高浓度无患子提取液的澄清、稳定的洗涤剂
KR20130141535A (ko) 염모제
EP3998059A9 (fr) Préparations douces en tant que moyen de nettoyage ou de soin permettant d'éliminer les hydrates de carbone ou les colorations
JPH09221503A (ja) 界面活性剤への溶解性が改良されたバイオポリマー
WO2015016054A1 (fr) Composition d'émulsion
WO2014132784A1 (fr) Composition de gel pour la peau
WO2025181601A1 (fr) Composition cosmétique pour le soin de l'acné
WO2022162620A2 (fr) Composition de nettoyant assurant un dépôt amélioré d'acide salicylique pour le traitement de l'acné
JP2025530531A (ja) ソホロ脂質および乳酸を含む組成物
WO2025181773A1 (fr) Composition comprenant un biotensioactif et de l'acide salicylique
US20250177273A1 (en) Coacervate cleansing composition
JP7551928B2 (ja) グリコリピド及びサリチル酸誘導体を含む組成物
FR3161561A3 (fr) Composition cosmétique pour le soin de l’acné
JP2024000268A (ja) 糖脂質及びクエン酸誘導体を含む組成物
JP5025163B2 (ja) 新規な毛髪処理剤
US20250154435A1 (en) Method of cleaning
FR3158437A3 (fr) Composition nettoyante coacervat
US20240350396A1 (en) Skin perfecting and tightening compositions
JP2006232766A (ja) 皮膚化粧料
CN119497607A (zh) 包含糖脂、牛磺酸盐表面活性剂和氨基酸表面活性剂的组合物
JP2025001451A (ja) 糖脂質、タウリン界面活性剤、及びアミノ酸界面活性剤を含む組成物
FR3149785A3 (fr) Compositions perfectrices et raffermissantes pour la peau
FR3151210A3 (fr) Composition comprenant un glycolipide, un tensioacatif taurate et un tensioacatif acide aminé

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 25706021

Country of ref document: EP

Kind code of ref document: A1